Cargando…
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Autores principales: | Wang, Manli, Cao, Ruiyuan, Zhang, Leike, Yang, Xinglou, Liu, Jia, Xu, Mingyue, Shi, Zhengli, Hu, Zhihong, Zhong, Wu, Xiao, Gengfu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7054408/ https://www.ncbi.nlm.nih.gov/pubmed/32020029 http://dx.doi.org/10.1038/s41422-020-0282-0 |
Ejemplares similares
-
Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
por: Liu, Jia, et al.
Publicado: (2020) -
The anti-influenza virus drug, arbidol is an efficient inhibitor of SARS-CoV-2 in vitro
por: Wang, Xi, et al.
Publicado: (2020) -
Comprehensive interactome analysis of the spike protein of swine acute diarrhea syndrome coronavirus
por: Wang, Qingxing, et al.
Publicado: (2021) -
Emerging 2019 Novel Coronavirus (2019-nCoV) Pneumonia
por: Song, Fengxiang, et al.
Publicado: (2020) -
Aptamer-Gated Mesoporous Silica Nanoparticles for N Protein Triggered Release of Remdesivir and Treatment of Novel Coronavirus (2019-nCoV)
por: Zhang, Xiaohui, et al.
Publicado: (2022)